Iradimed (IRMD) News Today → Why Is Gold On a MASSIVE rally? (From Huge Alerts) (Ad) Free IRMD Stock Alerts $42.03 -0.62 (-1.45%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 6, 2024 | finance.yahoo.comIRadimed Corporation (NASDAQ:IRMD) Q1 2024 Earnings Call TranscriptMay 5, 2024 | finance.yahoo.comIRADIMED CORPORATION Just Beat EPS By 6.7%: Here's What Analysts Think Will Happen NextMay 4, 2024 | finance.yahoo.comIRADIMED First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | marketbeat.comIradimed Corporation (NASDAQ:IRMD) Declares Quarterly Dividend of $0.15Iradimed Corporation (NASDAQ:IRMD) declared a quarterly dividend on Thursday, May 2nd. Shareholders of record on Monday, May 20th will be given a dividend of 0.15 per share by the medical equipment provider on Thursday, May 30th. This represents a $0.60 annualized dividend and a yield of 1.34%. The ex-dividend date is Friday, May 17th.May 3, 2024 | marketbeat.comIradimed (NASDAQ:IRMD) Issues Q2 2024 Earnings GuidanceIradimed (NASDAQ:IRMD) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.360-0.390 for the period, compared to the consensus estimate of 0.370. The company also issued revenue guidance of $17.6 millionillion-$17.8 millionillion, compared to the consensus estimate of $17.9 millionillion.May 2, 2024 | finance.yahoo.comiRadimed Corp (IRMD) Reports Record Q1 Revenue, Surpasses Analyst EstimatesMay 2, 2024 | globenewswire.comIRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per ShareMay 1, 2024 | msn.comiRadimed Q1 2024 Earnings PreviewApril 30, 2024 | finance.yahoo.comHere's Why We Think IRADIMED (NASDAQ:IRMD) Is Well Worth WatchingApril 26, 2024 | marketbeat.comIradimed (IRMD) Scheduled to Post Quarterly Earnings on ThursdayIradimed (NASDAQ:IRMD) will be releasing earnings before the market opens on Thursday, May 2, Zacks reports.April 25, 2024 | globenewswire.comIRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2ndApril 25, 2024 | marketbeat.comEquities Analysts Offer Predictions for Iradimed Corporation's Q1 2024 Earnings (NASDAQ:IRMD)Iradimed Corporation (NASDAQ:IRMD - Free Report) - Research analysts at Roth Capital issued their Q1 2024 earnings estimates for shares of Iradimed in a note issued to investors on Monday, April 22nd. Roth Capital analyst J. Wittes expects that the medical equipment provider will earn $0.31 per sApril 25, 2024 | marketbeat.comIradimed (NASDAQ:IRMD) Receives Buy Rating from Roth CapitalRoth Capital reaffirmed a "buy" rating on shares of Iradimed in a report on Monday.April 24, 2024 | benzinga.comiRadimed Stock (NASDAQ:IRMD), Analyst Ratings, Price Targets, PredictionsApril 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Alcon (ALC) and Iradimed (IRMD)April 22, 2024 | marketbeat.comIradimed (NASDAQ:IRMD) Rating Reiterated by Roth MkmRoth Mkm reissued a "buy" rating and set a $65.00 price target on shares of Iradimed in a research note on Monday.April 5, 2024 | marketbeat.comIradimed's (IRMD) "Buy" Rating Reaffirmed at Singular ResearchSingular Research reissued a "buy" rating on shares of Iradimed in a research report on Monday.April 2, 2024 | marketbeat.comIradimed Corporation (NASDAQ:IRMD) Sees Significant Increase in Short InterestIradimed Corporation (NASDAQ:IRMD - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 112,900 shares, an increase of 11.0% from the February 29th total of 101,700 shares. Based on an average daily volume of 54,200 shares, the short-interest ratio is presently 2.1 days. Approximately 1.4% of the shares of the stock are short sold.March 20, 2024 | marketbeat.comResource Consulting Group Inc. Purchases New Stake in IRadimed Co. (NASDAQ:IRMD)Resource Consulting Group Inc. acquired a new position in IRadimed Co. (NASDAQ:IRMD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 103,000 shares of the medical equipment provider's stock,March 18, 2024 | marketbeat.comIRadimed Co. (NASDAQ:IRMD) Sees Significant Growth in Short InterestIRadimed Co. (NASDAQ:IRMD - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 101,700 shares, an increase of 5.7% from the February 14th total of 96,200 shares. Currently, 1.3% of the company's shares are sold short. Based on an average daily volume of 52,200 shares, the days-to-cover ratio is presently 1.9 days.March 15, 2024 | finance.yahoo.comIRMD Jul 2024 60.000 callMarch 13, 2024 | globenewswire.comIRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceMarch 13, 2024 | wsj.comiRadimed Corp.February 26, 2024 | marketbeat.comSG Capital Management LLC Buys New Shares in IRadimed Co. (NASDAQ:IRMD)SG Capital Management LLC acquired a new stake in shares of IRadimed Co. (NASDAQ:IRMD - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,358 shares of the medical equipment provider's stock, valued at approxFebruary 26, 2024 | finance.yahoo.comCalculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)February 26, 2024 | finance.yahoo.comCalculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)February 23, 2024 | marketbeat.comEAM Investors LLC Sells 21,092 Shares of IRadimed Co. (NASDAQ:IRMD)EAM Investors LLC reduced its stake in shares of IRadimed Co. (NASDAQ:IRMD - Free Report) by 50.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,476 shares of the medical equipmentFebruary 20, 2024 | marketbeat.comIRadimed (NASDAQ:IRMD) Shares Gap Down to $46.76IRadimed (NASDAQ:IRMD) Shares Gap Down to $46.76February 19, 2024 | finance.yahoo.comShould You Invest in IRadimed Corporation (IRMD)?February 17, 2024 | finance.yahoo.comIRMD Mar 2024 40.000 callFebruary 17, 2024 | finance.yahoo.comIRMD Mar 2024 45.000 putFebruary 15, 2024 | finance.yahoo.comIRMD Feb 2024 44.520 callFebruary 11, 2024 | finance.yahoo.comInstitutional investors own a significant stake of 39% in IRadimed Corporation (NASDAQ:IRMD)February 9, 2024 | finance.yahoo.comIRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call TranscriptFebruary 8, 2024 | finance.yahoo.comiRadimed Corp (IRMD) Reports Record Revenues and Robust Earnings Growth in Q4 and Full-Year 2023February 8, 2024 | marketbeat.comIRadimed (NASDAQ:IRMD) Updates Q1 2024 Earnings GuidanceIRadimed (NASDAQ:IRMD) updated its first quarter 2024 earnings guidance. The company provided EPS guidance of 0.330-0.350 for the period, compared to the consensus estimate of 0.410. The company also issued revenue guidance of $17.0 millionillion-$17.3 millionillion, compared to the consensus estimate of $17.6 millionillion.February 8, 2024 | markets.businessinsider.comIRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial ResultsFebruary 8, 2024 | washingtonpost.comIRadimed: Q4 Earnings SnapshotFebruary 7, 2024 | benzinga.comiRadimed's Earnings OutlookFebruary 7, 2024 | msn.comiRadimed Q4 2023 Earnings PreviewFebruary 7, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Iradimed (IRMD)February 1, 2024 | finance.yahoo.comIRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.February 1, 2024 | seekingalpha.comIRadimed: Caution On The Valuation Of This Excellent CompanyJanuary 9, 2024 | finance.yahoo.comIRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 RevenueJanuary 7, 2024 | finance.yahoo.comWhat Is IRadimed Corporation's (NASDAQ:IRMD) Share Price Doing?January 2, 2024 | finance.yahoo.comIRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 27, 2023 | marketbeat.comRoger E. Susi Sells 5,000 Shares of IRadimed Co. (NASDAQ:IRMD) StockIRadimed Co. (NASDAQ:IRMD - Get Free Report) CEO Roger E. Susi sold 5,000 shares of IRadimed stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $46.00, for a total transaction of $230,000.00. Following the sale, the chief executive officer now owns 167,950 shares of the company's stock, valued at approximately $7,725,700. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.December 20, 2023 | marketbeat.comIRadimed Co. (NASDAQ:IRMD) CEO Sells $220,400.00 in StockIRadimed Co. (NASDAQ:IRMD - Get Free Report) CEO Roger E. Susi sold 5,000 shares of the firm's stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $44.08, for a total value of $220,400.00. Following the sale, the chief executive officer now directly owns 177,950 shares in the company, valued at approximately $7,844,036. The sale was disclosed in a document filed with the SEC, which is accessible through this link.December 18, 2023 | benzinga.comWednesday Is Your Last Chance To Buy iRadimed Before The Dividend PayoutDecember 14, 2023 | marketbeat.comIRadimed Co. (NASDAQ:IRMD) Director James B. Hawkins Sells 972 SharesIRadimed Co. (NASDAQ:IRMD - Get Free Report) Director James B. Hawkins sold 972 shares of IRadimed stock in a transaction dated Tuesday, December 12th. The shares were sold at an average price of $43.40, for a total value of $42,184.80. Following the sale, the director now owns 39,348 shares of the company's stock, valued at $1,707,703.20. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. IRMD Media Mentions By Week IRMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRMD News Sentiment▼1.870.53▲Average Medical News Sentiment IRMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRMD Articles This Week▼02▲IRMD Articles Average Week Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OFIX News Today BVS News Today SRDX News Today SIBN News Today PLSE News Today FNA News Today OSUR News Today ANIK News Today CERS News Today NVRO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRMD) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
